Douglas Evan Godshall
CIK 1404227 · President & CEO · last filed 2024-05-31
Douglas Evan Godshall is a President & CEO who has filed 129 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for SWAV, was dated May 31, 2024. Across all open-market trades the lifetime net is −$133.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SWAV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SIDNEY, C3 2000
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Shockwave Medical, Inc. (SWAV) Delisted | President & CEO | 0 | $334.75 | $0 | -$109.80M | 50 | 2024-05-31 |
| EYPT | Director | 8,016 | $0.36 | $2.9K | $29.8K | 8 | 2021-06-23 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 6 | 2017-12-19 |
| HeartWare International, Inc. (HTWR) Delisted | President & Chief Exec Officer | 0 | — | — | -$24.00M | 52 | 2016-08-24 |
Recent Filings
129 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-31 | Shockwave Medical, Inc. (SWAV) Delisted | Disp (D) | −151,629 | $0 | EDGAR |
| 2024-05-03 | Shockwave Medical, Inc. (SWAV) Delisted | Tax (F) | −1,144 | -$377.3K | EDGAR |
| 2024-02-21 | Shockwave Medical, Inc. (SWAV) Delisted | Tax (F) | −9,989 | -$2.55M | EDGAR |
| 2024-02-16 | Shockwave Medical, Inc. (SWAV) Delisted | Mixed | — | -$2.28M | EDGAR |
| 2024-02-06 | Shockwave Medical, Inc. (SWAV) Delisted | Tax (F) | −9,136 | -$2.07M | EDGAR |
| 2024-02-02 | Shockwave Medical, Inc. (SWAV) Delisted | Grant (A) | +19,013 | $0 | EDGAR |
| 2024-01-18 | Shockwave Medical, Inc. (SWAV) Delisted | Mixed | +11,828 | -$4.37M | EDGAR |
| 2024-01-16 | — | Notice (144) | −25,000 | -$5.40M | EDGAR |
| 2024-01-08 | Shockwave Medical, Inc. (SWAV) Delisted | Mixed | — | -$1.97M | EDGAR |
| 2024-01-05 | — | Notice (144) | −10,000 | -$1.96M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.